Abingworth LLP 13D and 13G filings for Sierra Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-11 4:30 pm Sale | 2022-07-01 | 13D | Sierra Oncology, Inc. SRRA | Abingworth LLP | 0 0.000% | -2,193,626 (Position Closed) | Filing |
| 2022-03-21 4:52 pm Unchanged | 2022-03-10 | 13D | Sierra Oncology, Inc. SRRA | Abingworth LLP | 2,193,626 8.900% | 0 (Unchanged) | Filing |
| 2022-02-10 5:00 pm Purchase | 2022-01-31 | 13D | Sierra Oncology, Inc. SRRA | Abingworth LLP | 2,193,626 11.300% | 150,000 (+7.34%) | Filing |
| 2021-11-05 4:40 pm Purchase | 2021-11-05 | 13D | Sierra Oncology, Inc. SRRA | Abingworth LLP | 2,043,626 12.600% | 7,874 (+0.39%) | Filing |